Royal Bank Of Canada Nant Health, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.38 - $0.61 $66 - $107	176 Added 18.86%	1,109 $0
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $1,250 - $2,322	-2,978 Reduced 76.14%	933 $0
Q1 2022 May 16, 2022	SELL	$0.75 - $1.08 $3,254 - $4,686	-4,339 Reduced 52.59%	3,911 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.94 - $1.85 $3,145 - $6,190	3,346 Added 68.23%	8,250 $8,000
Q3 2021 Nov 15, 2021	BUY	$1.61 - $2.41 $2,210 - $3,308	1,373 Added 38.88%	4,904 $8,000
Q2 2021 Aug 16, 2021	BUY	$2.25 - $3.37 $7,944 - $11,899	3,531 New	3,531 $8,000

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.